How scaling up clinical research in Africa can benefit society and the economy
More investment is needed in clinical research if Africa is to manage the double disease burden of infectious diseases and non-communicable conditions.
Vice President, EMEA Thought Leadership, IQVIA since 2010. IQVIA is a global Life Sciences company providing services to healthcare and life sciences stakeholders from clinical development through to healthcare delivery. Thought Leadership is a team providing perspective on key Life sciences and Healthcare issues. Each year, we publish white papers and other collateral on a broad range of topics, from commercial perspective on the Pharmaceutical industry, Healthcare services, EU Health Policy, Global Public Health and the impact of innovation in Healthcare. Our published work can be found here: https://www.iqvia.com/locations/emea/emea-thought-leadership
More investment is needed in clinical research if Africa is to manage the double disease burden of infectious diseases and non-communicable conditions.
Healthcare systems worldwide are facing increasing stress, spending waste and reduced capacity, which could be avoided – more AI in healthcare can help.
Antimicrobial resistance is known as a quiet pandemic but more data, investment, policy incentives and a holistic approach via One Health could defeat it.
Climate change has a direct impact on human health, but many healthcare systems have not committed to net zero. The sector must reduce its carbon footprint.
The pandemic accelerated the adoption of digital healthcare technologies but progress varies between countries. What can we learn from successful digital healthcare systems?
Commercially-led clinical development activity has been neglected in Africa; that must change with the continent's evolving population and health profile.